A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Find insight on Novarti, Sanofi and more in the latest Market Talks covering Health Care.

MOUNTAIN VIEW, CA / ACCESS Newswire / June 9, 2025 / Pactum, a leading Agentic AI platform for enterprise procurement, today ...

In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal ...

As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes ...

Novartis admitted the email broke several rules set out in the U.K. marketing code. In a long response to the PMCPA, the ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes? Let's find out.

Detailed data will be presented at a future medical meeting and submitted for regulatory review later this year.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...